Andrew Goulian

Mr. Andrew Goulian

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AGAndrew Goulian
Andrew Goulian
BGBrielle Goldstein
Brielle Goldstein
MSMaarouf A. Saad
Maarouf A. Saad
Background/Objectives: Regenerative therapies have gained interest in orthopedic applications for their potential to enhance tissue regeneration, functional recovery, and pain modification. This review evaluates the clinical efficacy of platelet-rich plasma (PRP), mesenchymal stem cells (MSCs), peptide-based treatments, and biomimetic materials in orthopedic care, with a focus on pain reduction and functional outcomes. Methods: A structured literature search in PubMed (January 2009–January 2025) identified 160 studies. After applying inclusion criteria prioritizing randomized controlled trials (RCTs) and clinical trials, 59 studies were included: 20 on PRP, 20 on MSCs, 10 on peptide therapies, and 7 on biomimetics. Data extraction focused on pain reduction and functional recovery, with risk of bias assessed using the Cochrane Risk of Bias (RoB) tool and ROBINS-I tool. A random-effects meta-regression analysis was conducted to evaluate the impact of therapy type, sample size, and risk of bias on reported pain reduction outcomes. Results: Meta-regression analysis identified MSC therapy as the most effective intervention for pain reduction (β = 8.45, p < 0.05), with PRP and peptide-based therapies showing moderate improvements, and biomimetic therapies demonstrating the lowest effect. PRP provided short-term pain relief, particularly in acute injuries and tendon repair, though inconsistencies in preparation methods limited success in chronic conditions. MSC therapies demonstrated cartilage regeneration and early osteoarthritis improvement, but high costs and ethical concerns remain barriers to widespread adoption. Peptide-based therapies and biomimetic materials, including engineered scaffolds and autologous protein solutions, showed promise for infection control and wound healing, though further research is needed to optimize dosing, delivery methods, and long-term safety. Conclusions: Regenerative therapies offer significant potential in orthopedic care, with MSC therapies demonstrating the most reliable regenerative effects, PRP providing short-term symptomatic relief, and peptide-based and biomimetic treatments emerging as promising adjuncts. However, standardized protocols and large-scale clinical trials are needed to establish long-term efficacy and improve clinical translation for broader adoption.

12 May 2022 in Harm Reduction Journal
Verified
Journal Article
Open access
PDF file
AGAndrew Goulian
Andrew Goulian
MJMarie Jauffret-Roustide
Marie Jauffret-Roustide
SDSayon Dambélé
Sayon Dambélé
RSRajvir Singh
Rajvir Singh
RFRobert E. Fullilove
Robert E. Fullilove

Verified
Journal Article
Open access
PDF file
AGAndrew Goulian
Andrew Goulian
DYDavid Yee
David Yee
Background/Objectives: Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy with poor prognosis, particularly in metastatic cases. The Ki-67 proliferation index is a recognized marker of tumor aggressiveness, yet its role in guiding diagnostic imaging and surgical decision-making remains underexplored. This study evaluates Ki-67’s predictive value for metastasis at diagnosis, leveraging artificial intelligence (AI) to inform personalized, minimally invasive strategies for ACC management. Methods: We retrospectively analyzed 53 patients with histologically confirmed ACC from the Adrenal-ACC-Ki67-Seg dataset in The Cancer Imaging Archive. All patients had Ki-67 indices from surgical specimens and preoperative contrast-enhanced CT scans. Descriptive statistics, t-tests, ANOVA, and multivariable logistic regression evaluated associations between Ki-67, tumor size, age, and metastasis. Random Forest classifiers—with and without the Synthetic Minority Oversampling Technique (SMOTE)—were developed to predict metastasis. A Ki-67-only model served as a baseline comparator. Model performance was assessed using the area under the curve (AUC) and DeLong’s test. Results: Patients with metastatic disease had significantly higher Ki-67 indices (mean 39.4% vs. 21.6%, p < 0.05). Logistic regression identified Ki-67 as the sole significant predictor (OR = 1.06, 95% CI: 1.01–1.12). The Ki-67-only model achieved an AUC of 0.637, while the SMOTE-enhanced Random Forest achieved an AUC of 0.994, significantly outperforming all others (p < 0.001). Conclusions: Ki-67 is significantly associated with metastasis at ACC diagnosis and demonstrates independent predictive value in regression analysis. However, integration with machine learning models incorporating tumor size and age significantly improves overall predictive accuracy, supporting AI-assisted risk stratification and precision imaging strategies in adrenal cancer care.

8 October 2024 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Closed access
PDF file
YAYavar Abgin
Yavar Abgin
KUKayla Umemoto
Kayla Umemoto
AGAndrew Goulian
Andrew Goulian
MVMissael Vasquez
Missael Vasquez
SPSean Polster
Sean Polster
DTDennis M. Tang
Dennis M. Tang
Artificial intelligence large language models (LLMs), such as Chat Generative Pre-Trained Transformer 4 (Chat-GPT) by OpenAI and Bard by Google, emerged in 2022 as tools for answering questions, providing information, and offering suggestions to the layperson. These LLMs impact how information is disseminated and it is essential to compare their answers to experts in the corresponding field. The International Consensus Statement on Endoscopic Skull-Base Surgery 2019 (ICAR:SB) is a multidisciplinary international collaboration that critically evaluated and graded the current literature. Evaluate the accuracy and completeness of Chat-GPT and Bard responses to questions derived from the ICAR:SB policy statements. Thirty-four questions were created based on ICAR:SB policy statements and input into Chat-GPT and Bard. Two rhinologists and two neurosurgeons graded the accuracy and completeness of LLM responses, using a 5-point Likert scale. The Wilcoxon rank-sum and Kruskal–Wallis tests were used for analysis. Online. None. Compare the mean accuracy and completeness scores between (1) responses generated by Chat-GPT versus Bard and (2) rhinologists versus neurosurgeons. Using the Wilcoxon rank-sum test, there were statistically significant differences in (1) accuracy (p < 0.001) and completeness (p < 0.001) of Chat-GPT compared with Bard; and (2) accuracy (p < 0.001) and completeness (p < 0.001) ratings between rhinologists and neurosurgeons. Chat-GPT responses are overall more accurate and complete compared with Bard, but both are very accurate and complete. Overall, rhinologists graded lower than neurosurgeons. Further research is needed to better understand the full potential of LLMs.

1 January 2023 in Digital Health
Verified
Journal Article
Open access
KPKyle Peer
Kyle Peer
JCJonathan Cotliar
Jonathan Cotliar
AGAndrew Goulian
Andrew Goulian
During recruitment for a large, decentralized clinical trial for high-risk individuals with COVID-19, respondents were either transferred in real-time to a clinical research coordinator (i.e. warm transfer), or a callback time was arranged. A retrospective analysis was conducted on 2341 respondents comparing the rate of enrollment among those who were warm-transferred and those for whom a callback was arranged. A respondent who warm-transferred was significantly more likely to enroll in the clinical trial.

1 March 2026 in American Journal of Men's Health
Verified
Journal Article
Open access
AGAndrew Goulian
Andrew Goulian
AAAtieh Ashkezari
Atieh Ashkezari
SESriram V. Eleswarapu
Sriram V. Eleswarapu
Testosterone deficiency in men is often attributed to aging or biology, yet hormone levels also reflect social determinants of health (SoDH) and masculinity-related stressors. This study applied the Healthy People 2030 SoDH framework to examine biological, behavioral, and social predictors of testosterone deficiency in U.S. men. Data were analyzed from four National Health and Nutrition Examination Survey (NHANES) cycles (2011–2016 and 2021–2023), including 10,357 men aged ≥18 years with valid total testosterone measurements. Men reporting exogenous testosterone therapy were excluded. Testosterone deficiency was defined as total serum testosterone <300 ng/dL. Survey-weighted, age-adjusted multivariable logistic regression models examined biological, behavioral, and SoDH domains. Testosterone deficiency prevalence was 25.7%, declining from 28.1% in 2011–2012% to 20.3% in 2021–2023 ( P -trend < .01). Independent predictors included obesity (AOR = 2.69, 95% CI [2.36–3.06]), impaired fasting glucose (AOR = 1.55, 95% CI [1.27–1.90]), diabetes-range glucose (AOR = 2.92, 95% CI [2.03–4.21]), and prolonged sedentary time ≥ 8 h/day (AOR = 1.39, 95% CI [1.14–1.70]). Men without a usual source of care had higher odds (AOR = 1.27, P < .05). Current smokers (AOR = .79, P < .05) and never-married men (AOR = .70, P < .001) had lower odds. Testosterone deficiency is shaped by metabolic, behavioral, and relational factors rather than socioeconomic markers alone. These findings support framing testosterone deficiency as a biopsychosocial condition and highlight the value of integrating endocrine and social-contextual perspectives in men’s health research and clinical care.